Cartilagine di squalo

Bibliografia

1. Folkman J.
   Angiogenesis in cancer vascular, rheumatoid and other disease.
   Nature Medicine, 1: 27-31. 1995.
2. Hunt TK.
   Wound repair and wound infection: Theory and surgical practice.
   New York, NY, Appleton-Century-Crofts, 1980.
3. Folkman J.
   Angiogenesis
   Biology of Endothelial Cell ( Jaffe EA. ed) Boston: Martinus Nijhoff Publishers, pp 412-428, 1984.
4. Folkman J.
   What is the evidence that tumors are angiogenesis dependent?
   J. Natl Cancer Inst 82: 4-6, 1989.
5. Kieser A, Weich H.A, Brandner G, et al.
   Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.
   Oncogene 9: 963-969, 1994.
6. Liotta L.A., Steeg P.S., and Steler-Stevenson W.G.
   Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.
   Cell 64: 327, 1991.
7. Fidler I.J, Ellis LM
   The implications of angiogenesis for the biology and therapy of cancer metastasis.
   Cell 79 185-188, 1994.
8. Rastinejad F., Polverini PJ, Bouck NP
   Regulation of the activity of a new inhibitor of angiogenesis by a cancer-suppressor gene.
   Cell 56: 345-355, 1989.
9. Bouck N.P.
   Tumor angiogenesis: the role of oncogenes and tumor suppressor genes
   Cancer Cell 2: 179-185, 1990.
10. D’Amore PA
    Capillary growth: a two-cell System
    Semin Cancer Biol 3: 49-56, 1992.
11. Leibovich S.J., Polverini PJ., Shepared HM., Wiseman DM, Shively V., Nuseir N.
    Macrophage-induced angiogenesis is mediated by Tumor Necrosis Factor alfa
    Nature 239: 630-632, 1987.
12. Hockel M, Jung W, Vaupel P., et al.
    Purified monocyte-derived angiogenic substance (angiotropin) induces controlled angiogenesis associated with regulated tissue proliferation in rabbit skin
    J Clin Invest 82: 1075-1090, 1988.
13. Bashkin P., Doctrow S., Klagsbrun M, et al.
    Basic Fibroblast Growth Factor binds to subendothelial extra-cellular matrix and is released by heparinase and heparinlike molecules
    Biochem 28: 1737-1743, 1989.
14. Folkman J., Merler E., Abemathy C., Williams G.
    Isolation of a tumor factor responsible for angiogenesis.
    J Exp Med 133: 275-288, 1971.
15. Folkman J. and Klagsbrun M.
    Angiogenic Factors
    Science 235: 442-447, 1987.
16. Ingber DE, Folkman J.
    How does extracellular matrix control capillary morfogenesis?
    Cell 58: 803-805, 1989.
17. Risau W.
    Angiogenic growth factors
    Progr Growth Factor RES 2: 71-79, 1990.
18. Schreiber A.B., et al.
    Trasforming Growth Factor-alfa: a more potent angiogenic mediator than Epidermal Growth Factor.
    Science 232: 150-1253. 1986.
19. Ishikawa F., et al.
    Identification of angiogenic activity and the cloning and the expression of Platelet, Derived endothelial cell Growth Factor.
    Nature 338: 557-562, 1989.
20. Plate K.H., Breier G., Weich H.A., and Risau W.
    Vascular Endothelial Growth Factor is a potential tumour angiogenesis factor in human gliomas in vivo.
    Nature 359: 845-848, 1992.
21. Shing Y.
    Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor.
    Science 223: 1296-1298, 1984
22. Fett J.W., et al.
    Isolation and characterization of angiogenin, an angiogenic protein from small carcinoma cells.
    Biochem 24: 5490-5496. 1995.
23. DiPietro LA and rctcr JP
    Angiogenic mac~I‑o~ gcs produce tIle angiogenic inhibitor thrombospondin
    l. AM J PATHOL 143: 678-684, 1993
24. Dameron KM, Volpert OV, Tainsky MA, Bouck N.
    Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin 1
    Science 265: 1582-1584, 1994
25. Rastinejad F, Polverini AJ, Bouck NP.
    Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
    Cell 56: 345-355, 1989
26. O’ Reilly M.S., et al.
    Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
    Cell 79: 315-328, 1994
27. Shark Cartilage Information Sheet, Office of Special Health Issues, Food and Drug Administration 3/27/97
28. Davis PF, He Y, Furneaux RH, et al.
    Inhibition of angiogenesis by oral ingestion of powdered shark cartilage in a rat model
    Microvascular Research 54(2): 178-182, 1997
29. Ronca G, Conte A
    Metabolic fate of partially depolymerized shark chondroitin sulfate in man
    International Journal of Clinical Pharmacology Research 13(suppl) 27-34, 1993
30. Henke CA, Roongta U, Mickelson DJ, et al.
    CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix
    Journal of Clinical Investigation 97(11): 2541-2552, 1996
31. Prudden JF
    The treatment of human cancer with agents prepared from bovine cartilage
    Journal of Biological Response Modifiers 4: 551-584, 1985
32. Miller D, Midwestern
    Regional Medical Center: Phase II Study of the Safety and Efficacy of Shark Cartilage (Cartilade) in Patients with Advanced or Metastatic Cancer (Summary Last Modified 9/97)
    clinical trial, closed, 12/05/96.
33. The Center for Alternative Medicine Research in Cancer at the University of Texas-Houston
    Health Science Center. Cartilage Summary
    web
34. Ronca F, Palmieri L, Panicucci P, et al.
    Anti-inflammatory activity of chondroitin sulfate
    Osteoarthritis and Cartilage 6(suppl A): 14-21, 1998.
35. Pipitone VR
    Chondroprotection with chondroitin sulfate
    Drugs Under Experimental and Clinical Research 17(1): 3-7, 1991
36. Fontenele JB, Viana GS, Xavier-Filho J, et al.
    Anti-inflammatory and analgesic activity of a water-soluble fraction from shark cartilage
    Brazilian Journal of Medical and Biological Research 29(5): 643-646, 1996
37. Fontenele JB, Araujo GB, de Alencar JW, et al.
    The analgesic and anti-inflammatory effects of shark cartilage are due to a peptide molecule and are nitric oxide (NO) system dependent
    Biological and Pharmaceutical Bulletin 20(11): 1151-1154, 1997
38. Moses MA, Sudhalter J, Langer R
    Identification of an inhibitor of neovascularization from cartilage
    Science 248(4961): 1408-1410, 1990
39. Bourgeois P, Chales G, Dehais J, et al.
    Efficacy and tolerability of chondroitin sulfate 1200mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo
    Osteoarthritis and Cartilage 6(suppl A): 25-30, 1998
40. Morreale P, Manopulo R, Galati M, et al.
    Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis
    Journal of Rheumatology 23(8): 1385-1391, 1996
41. Uebelhart D, Thonar E, Delmas PD, et al.
    Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study
    Osteoarthritis and Cartilage 6(suppl A): 39-46, 1998
42. Pettit GR, Ode RH
    Antineoplastic agents L: isolation and characterization of sphyrnastatins 1 and 2 from the hammerhead shark Sphyrna lewini
    Journal of Pharmaceutical Sciences 66(5): 757-758, 1977
43. Snodgrass MJ, Burke JD, Meetz, GD
    Inhibitory effect of shark serum on the Lewis lung carcinoma
    Journal of the National Cancer Institute 56(5): 981-983, 1976
44. Bodine AB, Luer CA, Gangjee SA, et al.
    In vitro metabolism of the pro-carcinogen aflatoxin B1 by liver preparations of the calf, nurse shark and clearnose skate
    Comparative Biochemistry and Physiology 94C(2): 447-453. 1989
45. Langer R, Brem H, Falterman K, et al.
    Isolation of a cartilage factor that inhibits tumor neovascularization
    Science 193(4247): 70-72, 1976
46. Sadove AM, Kuettner KE
    Inhibition of mammary carcinoma invasiveness with cartilage-derived inhibitor
    Surgical Forum 28: 499-501, 1977
47. Pauli BU, Memoli VA, Kuettner KE
    Regulation of tumor invasion by cartilage-derived anti-invasion factor in vitro
    Journal of the National Cancer Institute 67(1): 65-70, 1981
48. Lee A, Langer R
    Shark cartilage contains inhibitors of tumor angiogenesis
    Science 221(4616): 1185-1187, 1983
49. Ballantyne JS
    Jaws, the inside story. The metabolism of elasmobranch fishes
    Comparative Biochemistry and Physiology 118B(4): 703-742, 1997
50. Haddow A, Blake I
    Neoplasms in fish: a report of six cases with a summary of the literature
    Journal of Pathology and Bacteriology 36: 41-47, 1933
51. Schlumberger HG, Lucke B
    Tumors of fishes, amphibians, and reptiles
    Cancer Research 8: 657-754, 1948
52. Wellings SR
    Neoplasia and primitive vertebrate phylogeny: echinoderms, prevertebrates, and fishes--a review
    National Cancer Institute Monograph 31: 59-128, 1969
53. Oikawa T, Ashino-Fuse H, Shimamura M, et al.
    A novel angiogenic inhibitor derived from Japanese shark cartilage (I): extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis
    Cancer Letters, 51(3): 181-186
54. McGuire TR, Kazakoff PW, Hoie EB, et al.
    Antiproliferative activity of shark cartilage with and without tumor necrosis factor-a in human umbilical vein endothelium
    Pharmacotherapy 16(2): 237-244, 1996
55. Cataldi JM, Osborne DL
    Effects of shark cartilage on mammary tumor neovascularization in vivo and cell proliferation in vitro
    Federation of American Society of Experimental Biology Journal. 9(3): A135, 1995
56. Durie BG, Soehnlen B, Prudden JF
    Antitumor activity of bovine cartilage extract (Catrix-S) in the human tumor stem cell assay
    Journal of Biological Response Modifiers 4(6): 590-595, 1985
57. Riviere M, Alaoui-Jamali M, Falardeau P, et al.
    Neovastat: an inhibitor of angiogenesis with anti-cancer activity
    Proceedings of the American Association for Cancer Research 39: A317, 1998
58. Rosen J, Sherman WT, Prudden JF, et al.
    Immunoregulatory effects of Catrix
    Journal of Biological Response Modifiers 7(5): 498-512, 1988
59. McKinney EC, Haynes L, Droese AL
    Macrophage-like effector of spontaneous cytotoxicity from the shark
    Developmental and Comparative Immunology 10(4): 497-508, 1986
60. McKinney EC
    Shark cytotoxic macrophages interact with target membrane amino groups
    Cellular Immunology 127(2): 506-513, 1990
61. Gomes EM, Souto PR, Felzenszwalb I
    Shark-cartilage containing preparation protects cells against hydrogen peroxide induced damage and mutagenesis
    Mutation Research 367(4): 203-208, 1996
62. Romano CF, Lipton A, Harvey HA, et al.
    A phase II study of Catrix-S in solid tumors
    Journal of Biological Response Modifiers 4(6): 585-589, 1985
63. Puccio C, Mittelman A, Chun P, et al.
    Treatment of metastatic renal cell carcinoma with catrix
    Proceedings of the American Society of Clinical Oncology 13: A769, 1994.
64. Miller DR, Anderson GT, Stark JJ, et al.
    Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer
    Journal of Clinical Oncology 16(11): 3649-3655, 1998
65. Leitner SP, Rothkopf MM, Haverstick L, et al.
    Two phase II studies of oral dry shark cartilage powder in patients with either metastatic breast or prostate cancer refractory to standard treatment
    Proceedings of the American Society of Clinical Oncology 17: A240, 1998
66. Fossel E, Albright T, Zanella C.
    Trimethylamine oxide, a component of shark blood, exhibits chemopreventive properties
    Proceedings of the American Association for Cancer Research 34: A3281, 1993

| Contatti |